Ascend Wellness (OTC:AAWH) Upgraded by Zacks Research to "Hold" Rating

Key Points

• Ascend Wellness (OTC:AAWH) has been upgraded from a "strong sell" to a "hold" rating by Zacks Research.
• The stock price of Ascend Wellness opened at $0.86, with a twelve-month range of $0.26 to $0.98.
• Ascend Wellness engages in the cultivation and distribution of cannabis-related products, offering a wide range of brands including Common Goods and Ozone.

Ascend Wellness (OTC:AAWH - Get Free Report) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating in a research note issued on Monday,Zacks.com reports.

Ascend Wellness Stock Up 0.9%

AAWH stock opened at $0.86 on Monday. Ascend Wellness has a twelve month low of $0.26 and a twelve month high of $0.98. The company has a current ratio of 1.47, a quick ratio of 0.80 and a debt-to-equity ratio of 2.61. The company has a market capitalization of $175.82 million, a P/E ratio of -2.10 and a beta of 1.11. The firm has a 50 day simple moving average of $0.71 and a 200-day simple moving average of $0.47.

About Ascend Wellness

Ascend Wellness Holdings, Inc engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods in the United States. The company offers flower, pre-rolls, concentrates, vapes, edibles, tinctures, and other cannabis-related products under the Common Goods, SimplyHerb, Ozone, Ozone Reserve, Royale, Tunnel Vision, Miss Grass, Lowell Smokes, Edie Parker, 1906, and AiroPro brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.